Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
{ "products": [ { "_id": "66ed3750572086bc60674ea9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Paracetamol 650 mg", "description": "METAPECT PCM is a widely used medication formulated with Paracetamol 650 mg. It is primarily used to relieve pain and reduce fever. This product is trusted for its efficacy in treating a range of conditions, from headaches and muscle pain to fever associated with common colds and flu. METAPECT PCM is an essential in any medicine cabinet, offering fast-acting relief with minimal side effects when used as directed.\n\n \nKey Ingredients:\n \n\nParacetamol (650 mg): The active ingredient in METAPECT PCM, Paracetamol, is well-known for its analgesic (pain-relieving) and antipyretic (fever-reducing) properties. It is widely used in both over-the-counter and prescription medications for treating mild to moderate pain and fever.\n \nKey Benefits:\n \n\nPain Relief: Effective in relieving various types of mild to moderate pain, including headaches, toothaches, muscle aches, and back pain.\nFever Reduction: Helps lower body temperature in cases of fever, offering relief during colds, flu, and other infections.\nFast Acting: Provides quick relief, typically within 30 minutes to an hour of ingestion.\nSafe for Most: When taken as directed, Paracetamol is safe for most people, making it a go-to solution for pain and fever management.\n \nHow Does It Work?\n \n\nParacetamol works by blocking the production of certain chemicals in the brain called prostaglandins, which cause pain and inflammation. It acts on the hypothalamus, the part of the brain responsible for regulating body temperature, helping to reduce fever. Unlike NSAIDs (non-steroidal anti-inflammatory drugs), Paracetamol is gentle on the stomach and does not cause gastric irritation, making it suitable for a wide range of users.\n\n \nDirections for Use:\n \n\nDosage: Take one tablet (650 mg) every 4-6 hours as needed for pain or fever relief. Do not exceed the recommended dose of 4000 mg (or six tablets) in 24 hours unless directed by a physician.\nAdministration: Swallow the tablet whole with water, preferably after meals to avoid any potential stomach upset.\nConsultation: Always consult a doctor before use if you have liver or kidney issues or are taking other medications.\n \nSide Effects:\n \n\nWhile METAPECT PCM is generally well-tolerated, some individuals may experience mild side effects, including:\n\nNausea or Vomiting\nDizziness\nAllergic Reactions (rash, itching, swelling)\nLiver Damage (in case of overdose or prolonged use) If you experience any severe side effects or symptoms of an allergic reaction, discontinue use immediately and consult a healthcare provider.\n ", "price": 33.0, "discountamount": 10.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "4000 mg", "back pain", "30 minutes", "one tablet", "wide range", "most people", "Pain Relief", "muscle pain", "six tablets", "fever relief", "Liver Damage", "common colds", "quick relief", "muscle aches", "Key Benefits", "METAPECT PCM", "acting relief", "prolonged use", "kidney issues", "various types", "Fever Reduction", "Key Ingredients", "fever management", "recommended dose", "other infections", "body temperature", "medicine cabinet", "other medications", "active ingredient", "mild side effects", "Paracetamol 650 mg", "Allergic Reactions", "gastric irritation", "healthcare provider", "severe side effects", "reducing) properties", "minimal side effects", "mild to moderate pain", "potential stomach upset", "prescription medications", "non-steroidal anti-inflammatory drugs" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1980, "imageuri": "https://productimages.withfloats.com/actual/66ed3754804354f4ee30d92f.png", "tileimageuri": "https://productimages.withfloats.com/tile/66ed3754804354f4ee30d92f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-20T08:50:24.296Z", "updatedon": "2026-03-14T05:28:06.294Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/paracetamol-650-mg/1980", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METAPECT PCM ", "category": "GENERAL RANGE", "tags": [ "What is the use of paracetamol?", "Paracetamol uses", "Paracetamol Tablets", "Is PCM 650 a Paracetamol?", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6662a5fc870e7b20c49e6381", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sodibicarb Bicarbonate 650 mg", "description": "SODIBICARB 650 EC\nSodibicarb Bicarbonate 650 mg\nSodibicarb Bicarbonate 650 mg\nDescription:\nSodibicarb 650 EC is a medication containing 650 mg of Sodibicarb Bicarbonate. This active ingredient plays a vital role in various physiological processes, particularly in the regulation of acid-base balance in the body.\n\nUses:\n\nAcid-Base Balance: Sodibicarb 650 EC is commonly used to treat conditions associated with an imbalance in acid-base levels, such as metabolic acidosis. It works by neutralizing excess acid in the blood, restoring the body's natural pH levels.\nDosage and Administration:\n\nThe dosage of Sodibicarb 650 EC may vary depending on the individual's condition and medical history. It is crucial to follow the prescribed dosage and administration instructions provided by a healthcare professional.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\n", "price": 63.0, "discountamount": 19.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "Uses", "body", "Order", "Email", "blood", "Dosage", "650 mg", "product", "WhatsApp", "imbalance", "individual", "conditions", "regulation", "medication", "vital role", "excess acid", "information", "sterisonline", "sterispharma", "mg Description", "medical history", "acid-base levels", "natural pH levels", "active ingredient", "acid-base balance", "SODIBICARB 650 EC", "metabolic acidosis", "Sodibicarb Bicarbonate", "healthcare professional", "administration instructions", "various physiological processes" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1489, "imageuri": "https://productimages.withfloats.com/actual/6662a5fff21358d53af45e8d.png", "tileimageuri": "https://productimages.withfloats.com/tile/6662a5fff21358d53af45e8d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T06:17:32.685Z", "updatedon": "2026-03-14T06:42:18.798Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sodibicarb-bicarbonate-650-mg/1489", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SODIBICARB 650 EC", "category": "NEPHROLOGYRANGE", "tags": [ "SODIBICARB 650 EC", "Sodibicarb Bicarbonate 650 mg", "Sodium bicarbonate 650 mg for kidneys", "Sodium bicarbonate 650 mg dosage", "Sodium bicarbonate tablets for kidney disease dose", "Sodium bicarbonate dosage for adults" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "662f401ddaf7a411d0a90c76", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SODIBICARB 650 EC ", "description": "SODIBICARB 650 EC \nSodibicarb Bicarbonate 650 mg\nSodibicarb 650 EC is a medication containing 650 mg of Sodium Bicarbonate, a widely used antacid known for its effectiveness in neutralizing stomach acid. This oral treatment provides quick relief from conditions such as heartburn, acid indigestion, and upset stomach by raising the pH level in the stomach, making it less acidic. It may also be used to alleviate symptoms caused by excessive acidity in the blood or urine. Convenient and safe for most users, Sodibicarb 650 EC is essential for those seeking immediate relief from acid-related discomfort. Always consult a healthcare provider for appropriate usage and dosage.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n", "price": 68.0, "discountamount": 21.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "blood", "urine", "dosage", "antacid", "pH level", "symptoms", "heartburn", "medication", "conditions", "most users", "stomach acid", "quick relief", "effectiveness", "oral treatment", "acid indigestion", "immediate relief", "SODIBICARB 650 EC", "excessive acidity", "appropriate usage", "Sodium Bicarbonate", "healthcare provider", "Sodibicarb Bicarbonate", "acid-related discomfort" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 778, "imageuri": "https://productimages.withfloats.com/actual/662f4020670596731f8ebd44.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/662f4020670596731f8ebd44.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-29T06:37:17.251Z", "updatedon": "2026-03-14T06:42:12.015Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sodibicarb-650-ec-/778", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sodibicarb Bicarbonate 650 mg", "category": "NEUROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a952bdada41ea9aeeec5e4a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide injection 8 mg", "description": "The semaglutide injection, 8 mg, contains a total of 8 mg of semaglutide, a long-acting GLP-1 receptor agonist. It is used under medical supervision as part of treatment for appropriate adults with type 2 diabetes mellitus and, depending on the specific approved product and indication, for cardiovascular risk reduction and chronic weight management.\n1. Product Overview & Specifications\nAn 8 mg/3 mL semaglutide pen contains 8 mg of the active medicine in a 3 mL delivery system. When specifically designed to provide 2 mg per weekly dose, the total quantity can provide four 2 mg doses.\nActive Ingredient: Semaglutide\nTotal Strength: 8 mg\nExample Presentation: 8 mg/3 mL multi-dose pen\nDrug Class: GLP-1 receptor agonist\nRoute: Subcutaneous injection\nCommon Injection Areas: Abdomen, thigh, or upper arm\nAdministration: Once weekly, according to the prescribed schedule\nMechanism of Action\nSemaglutide mimics the activity of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). It acts on GLP-1 receptors involved in blood-glucose regulation, digestion, and appetite.\nImproves glucose-dependent insulin release: Semaglutide encourages the pancreas to release insulin when blood glucose levels are elevated.\nReduces glucagon secretion: It lowers inappropriate glucagon release, helping reduce the amount of glucose produced by the liver.\nSlows gastric emptying: Semaglutide can delay the movement of food from the stomach, contributing to prolonged fullness.\nReduces appetite: Its effects on appetite-regulating pathways in the brain can decrease hunger and food intake.\n2. Primary Indications & Uses\nSemaglutide may be prescribed for several clinically established purposes depending on the specific formulation, approved labeling, and patient's medical condition.\nType 2 Diabetes Management\nSemaglutide can be used alongside appropriate diet and physical activity to improve blood-glucose control in adults with type 2 diabetes.\nCardiovascular Risk Reduction\nIn eligible adults with type 2 diabetes and established cardiovascular disease, certain semaglutide products have demonstrated a reduction in the risk of major cardiovascular events, including cardiovascular death, non-fatal heart attack, and non-fatal stroke.\nKidney Disease\nCertain semaglutide formulations and indications have demonstrated kidney-related benefits in specific populations. The appropriate product and indication should be determined by a healthcare professional.\nChronic Weight Management\nSemaglutide is also used for long-term weight management in eligible adults with obesity or overweight accompanied by weight-related health conditions, depending on the approved formulation and local prescribing guidance.\n3. Key Benefits of Semaglutide 8 mg Therapy\nClinical Area\nPotential Therapeutic Role\nBlood-Glucose Control\nHelps lower elevated blood glucose and improve glycemic control in appropriate patients.\nWeight Management\nReduces appetite and food intake, supporting sustained weight reduction when prescribed for this purpose.\nCardiovascular Health\nCertain approved semaglutide indications can reduce major cardiovascular event risk in eligible patients.\nMetabolic Support\nInfluences glucose regulation, appetite, insulin secretion, and glucagon activity.\nWeekly Administration\nA once-weekly injection can provide a convenient treatment schedule when prescribed.\n\n4. Side Effects & Safety Warnings\nCommon Adverse Reactions\nDigestive symptoms are among the most frequently reported adverse effects, particularly when treatment is initiated or the dose is increased.\nPossible side effects include:\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nBloating\nBelching\nIndigestion or heartburn\nReduced appetite\nThese effects may improve as the body becomes accustomed to treatment.\nFrequently Asked Questions\n1. How much weight can you lose with semaglutide?\nWeight reduction varies significantly between individuals and depends on the prescribed formulation, dose, treatment duration, diet, physical activity, and adherence. Clinical trials of approved weight-management regimens have demonstrated substantial average percentage weight loss over extended treatment periods.\n2. How much is 8 units of semaglutide in mL?\nOn a U-100 insulin syringe, 100 units corresponds to 1 mL, so 8 units corresponds to 0.08 mL. However, this conversion only describes syringe volume. It does not determine the amount of semaglutide in mg because the medication concentration varies between products. Always verify the exact concentration before measuring any dose.\n3. Is semaglutide injection safe for weight loss?\nSemaglutide can be an effective treatment for weight management when an approved formulation is prescribed to an eligible patient and used under appropriate medical supervision. It has important contraindications and warnings, including risks involving the gastrointestinal system, gallbladder, pancreas, kidneys, and thyroid C-cell tumors.\n4. How many mg of semaglutide are used for weight loss?\nThe appropriate dose depends on the specific semaglutide product. Weight-management treatment commonly begins with a lower dose and is gradually increased to a maintenance dose to improve tolerability. The maintenance dose should be determined according to the product's approved prescribing information and the healthcare professional's instructions.\n5. How much weight can I lose in 2 months with semaglutide?\nThere is no guaranteed amount of weight loss during the first two months. Individual results vary because treatment generally begins at a lower dose and is increased gradually. Diet, physical activity, starting weight, medical conditions, and adherence also affect the result.\n6. What happens when you stop semaglutide?\nAfter discontinuation, semaglutide gradually leaves the body. Appetite and food intake may increase as its effects decrease, and some people regain weight. Maintaining healthy eating and physical activity habits may help support weight management after treatment, but discontinuation should be discussed with a healthcare professional.\n7. How long does an 8 mg/3 mL semaglutide pen last?\nIf a specific 8 mg/3 mL pen is designed to deliver 2 mg per weekly dose, it contains four 2 mg doses and therefore provides approximately four weeks of treatment. The actual duration depends on the specific device and prescribed dosing instructions.\n8. What is semaglutide injection 8 mg used for?\nSemaglutide is used for approved indications such as improving blood-glucose control in type 2 diabetes and, depending on the formulation, supporting chronic weight management and reducing cardiovascular risk in eligible patients.\n9. What foods should be avoided while taking semaglutide?\nLarge, high-fat, greasy, or fried meals may worsen gastrointestinal symptoms such as nausea, bloating, and reflux. Smaller meals and balanced food choices may be easier to tolerate. Alcohol intake should also be discussed with a healthcare professional.\n10. Can you eat bananas while taking semaglutide?\nYes, bananas can generally be included in a balanced diet while using semaglutide. Portion size should be considered as part of an individual's overall calorie and carbohydrate intake, particularly for people managing diabetes.\n11. What is the best time of day to inject semaglutide?\nSemaglutide injections can generally be administered at any time of day, with or without meals, depending on the specific product instructions. The injection should be taken on the same day each week as prescribed.\n12. Will I lose weight during the first week of semaglutide?\nSome people may notice an early change in appetite or body weight, while others may not see a significant difference initially. Early treatment doses are generally introduced gradually to help the body adjust rather than to produce immediate maximum weight loss.\n13. How quickly does semaglutide start lowering blood sugar?\nSemaglutide begins acting after administration, but the degree and timing of blood-glucose improvement vary. Significant treatment effects develop progressively, particularly as the prescribed dose is gradually adjusted.\n14. What should I do if I miss a semaglutide dose?\nThe correct missed-dose procedure depends on the specific semaglutide product. Follow the instructions supplied with your prescribed product. Do not take an extra dose to compensate for a missed injection.\n15. Where is the best place to inject semaglutide?\nSemaglutide is administered subcutaneously. Common injection sites include the abdomen, front of the thigh, or upper arm, according to the product instructions. Rotating injection locations can help reduce repeated irritation at one site.\nConclusion\nSemaglutide injection 8 mg contains semaglutide, a long-acting GLP-1 receptor agonist that influences blood-glucose regulation, glucagon secretion, gastric emptying, and appetite. Depending on the specific formulation and approved indication, semaglutide may be used for type 2 diabetes management, chronic weight management, and cardiovascular risk reduction in eligible patients.\nAn 8 mg/3 mL presentation designed for 2 mg weekly dosing can provide four weekly doses. However, semaglutide concentrations, pen designs, approved doses, and indications can differ between products. Treatment should therefore follow the exact product instructions and a healthcare professional's prescription.", "price": 7800.0, "discountamount": 2340.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2498, "imageuri": "https://productimages.withfloats.com/actual/6a952bdd8359c1b7edbc7468.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a952bdd8359c1b7edbc7468.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-31T07:23:06.814Z", "updatedon": "2026-08-31T07:23:06.814Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-8-mg/2498", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 8MG", "category": "DIABETIC RANGE", "tags": [ "Semaglutide injection 8 mg", "semaglutide injection 8 mg", "semaglutide 8 mg injection uses", "semaglutide 8 mg injection benefits", "semaglutide 8 mg injection dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a8c3838c90065ecdc86c757", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 4mg", "description": "SAMIGLUTIDE 4 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation contains 4 mg of semaglutide in 3 mL of solution, corresponding to approximately 1.34 mg/mL.\n\nSemaglutide is a GLP-1 receptor agonist that acts on physiological pathways involved in blood-glucose control, appetite, and gastrointestinal function. Its use should be based on the approved indication for the specific product and the advice of a qualified healthcare professional.\n\nProduct Overview\nProduct: SAMIGLUTIDE 4 MG\nActive substance: Semaglutide\nStrength: 4 mg/3 mL\nApproximate concentration: 1.34 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute: Subcutaneous administration, according to the applicable product instructions\n\nThe 4 mg/3 mL concentration is also associated with certain approved semaglutide products. However, this does not mean that their dosing schedules, indications, or administration instructions automatically apply to SAMIGLUTIDE 4 MG. The product-specific labeling should always be followed.\n\nWhat Is Semaglutide?\n\nSemaglutide is a medication belonging to the GLP-1 receptor agonist class. It acts similarly to the naturally occurring hormone glucagon-like peptide-1 (GLP-1).\n\nGLP-1 is involved in several processes related to metabolism. Its activity can influence insulin secretion, glucagon regulation, stomach emptying, and appetite. Depending on the particular semaglutide product and its regulatory authorization, semaglutide may be prescribed for conditions such as type 2 diabetes or chronic weight management in appropriately selected patients.\n\nBecause different semaglutide products can have different approved uses and formulations, treatment decisions should be based on the specific medicine being prescribed.\n\nSAMIGLUTIDE 4 MG Pre-Filled Pen\n\nSAMIGLUTIDE 4 MG is supplied in a pre-filled pen intended to provide a convenient format for subcutaneous administration.\n\nPre-filled devices can eliminate the need to draw medication from a conventional vial. Nevertheless, patients should be properly trained before using an injectable pen and should follow the instructions supplied with the specific product.\n\nThe pen should only be used according to its approved instructions, including the prescribed dose and administration schedule.\n\nStrength and Formulation\n\nEach stated 3 mL presentation contains 4 mg of semaglutide, giving a concentration of approximately 1.34 mg/mL.\n\nThe concentration of a medicine should not be confused with the amount delivered in every injection. The quantity administered depends on the design and dose settings of the particular pen.\n\nFor this reason, patients should not calculate or select their own dose based solely on the concentration printed on the package. The prescribed dose should come from the product's authorized instructions and the treating healthcare professional.\n\nHow Semaglutide Acts\n\nSemaglutide activates GLP-1 receptors, which are involved in the regulation of blood glucose and appetite.\n\nAmong its physiological effects, GLP-1 receptor activation can:\n\nSupport glucose-dependent insulin secretion.\nReduce inappropriate glucagon secretion when blood glucose is elevated.\nAffect gastrointestinal activity, including gastric emptying.\nInfluence appetite and food intake.\n\nThe overall response to treatment can vary between individuals and depends on factors such as the medical indication, prescribed dose, treatment duration, and other medicines being used.\n\nPotential Therapeutic Benefits\n\nWhen prescribed for an appropriate, authorized indication, semaglutide may form part of a broader treatment program.\n\nFor eligible individuals with type 2 diabetes, certain approved semaglutide medicines are used to improve glycemic control. Other approved semaglutide formulations have indications involving chronic weight management for qualifying patients.\n\nMedication should be considered alongside the broader treatment strategy recommended by a healthcare professional, which may include nutritional management, physical activity, glucose monitoring, and other appropriate interventions.\n\nPossible Side Effects\n\nLike other prescription medicines, semaglutide can cause unwanted effects.\n\nFrequently reported gastrointestinal reactions associated with semaglutide products include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort or pain\n\nNot every patient experiences these effects, and their severity can vary.\n\nSemaglutide products also have important safety considerations. Depending on the specific approved product, labeling includes warnings concerning conditions such as pancreatitis, gallbladder-related problems, severe gastrointestinal reactions, kidney problems associated with dehydration, and serious hypersensitivity reactions.\n\nPatients should provide their healthcare professional with a complete medical history before treatment begins.\n\nImportant Contraindications and Warnings\n\nCertain semaglutide products carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Serious hypersensitivity to semaglutide or an applicable component is also an important contraindication.\n\nThe exact warnings and contraindications applicable to SAMIGLUTIDE 4 MG should be confirmed against its current authorized product information in the relevant country.\n\nPatients should seek professional medical advice if they develop concerning symptoms during treatment.\n\nCorrect Administration\n\nSAMIGLUTIDE 4 MG should be administered only according to the prescription and instructions applicable to the product.\n\nBefore using a pre-filled pen, patients should receive appropriate instruction regarding:\n\nDose selection\nInjection technique\nInjection sites\nPen operation\nStorage\nDisposal of used needles or injection equipment\n\nThe dose or frequency should never be changed independently.\n\nA pre-filled injection pen should not be shared with another person, even if a new needle is attached. Sharing injectable medication devices can create a risk of transmitting infections and is contrary to appropriate safe-use practices.\n\nStorage\n\nStorage requirements should be determined from the official SAMIGLUTIDE 4 MG packaging and product information supplied with the medicine.\n\nPatients should not rely on storage instructions from a different semaglutide brand because formulations, devices, and stability requirements can differ between products.\n\nUse by Healthcare Professionals\n\nHealthcare professionals should assess whether SAMIGLUTIDE 4 MG is appropriate for an individual patient by considering the relevant diagnosis, treatment objectives, medical history, contraindications, concurrent medicines, and applicable regulatory requirements.\n\nParticular attention should be given to the distinction between different semaglutide products. Although they contain the same active ingredient, products may differ in:\n\nApproved indications\nConcentration\nPen design\nDose increments\nAdministration schedules\nStorage conditions\nRegulatory labeling\n\nThe product-specific prescribing information should therefore be consulted before treatment is initiated or adjusted.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can provide a practical method of administering an injectable medicine. Compared with a conventional vial-and-syringe presentation, the device may reduce some preparation steps and can be convenient for patients who have been appropriately trained.\n\nConvenience, however, should not take precedence over product authenticity, regulatory approval, correct dosing, proper storage, and professional medical supervision.\n\nSAMIGLUTIDE 4 MG: Key Points\n\nSAMIGLUTIDE 4 MG is described as a semaglutide injection containing 4 mg in 3 mL, supplied in a pre-filled pen.\n\nThe most important considerations are:\n\nSemaglutide is a GLP-1 receptor agonist.\nThe stated formulation is 4 mg/3 mL (approximately 1.34 mg/mL).\nAdministration is by the subcutaneous route when prescribed for that route.\nThe appropriate dose and frequency must come from the product-specific instructions and prescription.\nDosing information from another semaglutide brand should not automatically be applied.\nPatients should be informed about possible adverse reactions and relevant contraindications.\nThe pen must not be shared between patients.\nStorage and handling should follow the official product information.\nTreatment should be supervised by an appropriately qualified healthcare professional.\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 4 MG?\n\nSAMIGLUTIDE 4 MG is a semaglutide-containing injectable formulation described as 4 mg/3 mL, supplied in a pre-filled pen. Its approved use depends on the regulatory authorization applicable to the product and market.\n\nWhat does 4 mg/3 mL mean?\n\nIt indicates that the stated 3 mL presentation contains a total of 4 mg of semaglutide, equivalent to approximately 1.34 mg of semaglutide per mL.\n\nThis concentration alone should not be used to determine an individual's injection dose.\n\nIs SAMIGLUTIDE 4 MG a prescription medicine?\n\nSemaglutide medicines are prescription products in many jurisdictions. SAMIGLUTIDE 4 MG should be used only in accordance with applicable regulations, authorized product information, and professional medical advice.\n\nHow is SAMIGLUTIDE 4 MG administered?\n\nThe product is described as a subcutaneous injection. However, the exact dose, injection frequency, and pen operation should be determined from the SAMIGLUTIDE 4 MG product information and the patient's prescription.\n\nCan SAMIGLUTIDE 4 MG be taken together with another semaglutide medicine?\n\nPatients should not combine semaglutide-containing medicines or switch between them without medical supervision. Some approved semaglutide labels specifically advise against combining their product with another semaglutide-containing medicine or another GLP-1 receptor agonist.\n\nCan the dose be changed without consulting a doctor?\n\nNo. Patients should not increase, decrease, or otherwise modify the prescribed dose or injection schedule without guidance from their healthcare professional.\n\nConclusion\n\nSAMIGLUTIDE 4 MG – Semaglutide Injection 4 mg/3 mL (approximately 1.34 mg/mL) Pre-Filled Pen is a semaglutide-based injectable formulation designed for subcutaneous use according to its applicable product instructions.\n\nBecause semaglutide products can vary substantially in their approved indications, concentrations, devices, and dosing regimens, information from another semaglutide product should not be assumed to apply to SAMIGLUTIDE 4 MG.\n\nFor appropriate and safe use, patients and healthcare professionals should rely on the current official product information, local regulatory authorization, and individualized medical advice. Any questions concerning suitability, dosing, interactions, contraindications, or adverse effects should be discussed with a qualified healthcare professional.", "price": 6600.0, "discountamount": 1980.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2497, "imageuri": "https://productimages.withfloats.com/actual/6a8c383c0e00e8a5dab0c9d5.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c383c0e00e8a5dab0c9d5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:25:28.659Z", "updatedon": "2026-08-24T12:25:28.659Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-4mg/2497", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 4 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a8c35e76d1f6b0cbc0e2e40", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 2 mg", "description": "SAMIGLUTIDE 2 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation is Semaglutide Injection 2 mg/3 mL (0.68 mg/mL). Semaglutide belongs to the GLP-1 receptor agonist class and is a prescription medicine that should be used only under the supervision of an appropriately qualified healthcare professional.\n\nSAMIGLUTIDE 2 MG Composition\n\nEach 3 mL pre-filled pen is stated to contain:\n\nActive substance: Semaglutide\nStrength: 2 mg/3 mL\nConcentration: 0.68 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute of administration: Subcutaneous, according to the applicable product instructions\n\nSemaglutide acts on GLP-1 receptors, which are involved in blood-glucose regulation and appetite control. The approved uses, dosage regimen and strength available can differ according to the specific product and the regulations of the country in which it is supplied.\n\nWhat Is Semaglutide?\n\nSemaglutide is a synthetic peptide that mimics the activity of the naturally occurring hormone glucagon-like peptide-1 (GLP-1). By activating GLP-1 receptors, it can influence several physiological processes, including glucose-dependent insulin release, glucagon secretion, gastric emptying and appetite.\n\nThe appropriate dose and treatment schedule depend on the individual patient and the particular semaglutide formulation. Patients should follow their healthcare professional's instructions and should not alter the prescribed regimen independently.\n\nSAMIGLUTIDE 2 MG Pre-Filled Pen\n\nSAMIGLUTIDE 2 MG is presented as a pre-filled injection pen intended to provide a convenient method of administration when the medicine has been prescribed.\n\nSince semaglutide products can differ in concentration, pen design and dose-delivery mechanism, users should carefully verify the product label and prescribed dose before each administration. Particular care is important with injectable semaglutide products because differences in concentration or measurement methods can result in medication errors.\n\nPotential Medical Uses\n\nSemaglutide may be used for particular medical conditions depending on the formulation, regulatory approval and prescribing information applicable to the product.\n\nCertain approved semaglutide medicines are indicated for the treatment of type 2 diabetes, while other formulations have approved indications involving chronic weight management in eligible patients. Some products may also have additional approved indications for reducing specific cardiovascular risks.\n\nThe fact that semaglutide can be used for weight management does not mean that every semaglutide product is approved for that purpose. The authorization and labeling of SAMIGLUTIDE should therefore be confirmed from current official product documentation.\n\nHow Semaglutide Works\n\nSemaglutide activates GLP-1 receptors in the body. Its effects can contribute to improved regulation of blood glucose and reduced appetite and food intake. Depending on the approved indication, it may be prescribed together with dietary, physical-activity or other appropriate medical measures.\n\nIndividual responses can vary. Medical follow-up helps healthcare professionals evaluate treatment response, tolerability and whether treatment should be continued or modified.\n\nDosage and Administration\n\nSAMIGLUTIDE 2 MG should be administered only in accordance with the prescription and the manufacturer's current instructions.\n\nThe amount of semaglutide contained in a pen should not automatically be interpreted as the amount to inject at one time. Different products may use different concentrations, dose settings and administration schedules.\n\nFor approved semaglutide products, treatment may involve gradual dose increases for certain indications. Patients should never increase the dose, inject more frequently or repeat a missed dose without receiving appropriate medical instructions.\n\nPossible Side Effects\n\nSemaglutide can cause adverse effects, particularly gastrointestinal symptoms. Frequently reported effects may include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nAbdominal pain\n\nMore serious reactions are also possible. Product information for semaglutide medicines includes warnings relating to conditions such as pancreatitis and gallbladder disorders, among other potential risks.\n\nPersistent, severe or unusual symptoms should be discussed promptly with a healthcare professional. Patients should review the complete prescribing information supplied with their particular product.\n\nImportant Safety Information\n\nSemaglutide is not appropriate for everyone. For example, certain approved semaglutide products in the United States carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC), people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and individuals with a serious hypersensitivity to semaglutide or an ingredient in the relevant product.\n\nThese precautions should not automatically be assumed to apply identically to every semaglutide product worldwide. The manufacturer's labeling and the regulatory requirements of the relevant country should always be consulted.\n\nPatients should inform their healthcare professional about their medical history and other medicines before starting treatment.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can make injectable treatment more convenient by providing the medication in a ready-to-use delivery device. When used according to the manufacturer's instructions, the pen may simplify administration and help patients maintain their prescribed treatment routine.\n\nPatients should nevertheless receive appropriate guidance regarding injection technique, storage, handling and disposal. The convenience of a pen does not eliminate the need for medical supervision.\n\nStorage and Handling\n\nSAMIGLUTIDE 2 MG should be stored exactly as stated on its packaging and official product information. Appropriate storage conditions are important for maintaining the quality and stability of the medicine.\n\nBefore use, check the expiry date and inspect the packaging and medicine according to the manufacturer's instructions. Do not use the product if the packaging is damaged or if the solution has an appearance that does not meet the stated product requirements.\n\nConclusion\n\nSAMIGLUTIDE 2 MG – Semaglutide Injection 2 mg/3 mL (0.68 mg/mL) is a semaglutide-based injectable formulation supplied in a pre-filled pen. Semaglutide is a GLP-1 receptor agonist with established medical applications for appropriately selected patients, depending on the specific product and its regulatory authorization.\n\nSafe use requires adherence to the prescribed dose and administration schedule. Patients should not independently change their dose or frequency and should seek professional advice if they experience concerning adverse effects.\n\nBecause formulations, indications, strengths and regulatory requirements can vary between products and countries, the current official package insert and applicable regulatory labeling should be used to verify product-specific information.\n\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 2 MG?\n\nSAMIGLUTIDE 2 MG is described as a semaglutide injection containing 2 mg of semaglutide in 3 mL, with a stated concentration of 0.68 mg/mL, supplied in a pre-filled pen.\n\nIs SAMIGLUTIDE 2 MG used for weight management?\n\nSemaglutide is included in certain approved medicines used for chronic weight management in eligible patients. However, the indication for a specific SAMIGLUTIDE product must be confirmed from its current regulatory approval and official labeling.\n\nHow frequently is SAMIGLUTIDE 2 MG injected?\n\nThe correct frequency depends on the specific product and the prescription issued by the healthcare professional. Patients should not determine the injection schedule based solely on the amount printed on the pen.\n\nCan SAMIGLUTIDE 2 MG be taken without medical supervision?\n\nNo. Semaglutide is a prescription medicine in many jurisdictions and should be obtained and used through legitimate, appropriately regulated healthcare channels.\n\nIs SAMIGLUTIDE the same as other branded semaglutide medicines?\n\nNot necessarily. Products containing semaglutide can differ in manufacturer, formulation, concentration, delivery device, regulatory approval and approved indications. A specific product should not be described as identical to an approved branded medicine unless that claim can be verified through reliable regulatory and product documentation.\n\nWhat should patients check before using the pen?\n\nPatients should verify the medicine name, strength, prescribed dose, expiry date, storage conditions and administration instructions. If there is any uncertainty about the dose or operation of the pen, they should consult their pharmacist, prescriber or another qualified healthcare professional rather than guessing.", "price": 5600.0, "discountamount": 1680.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2496, "imageuri": "https://productimages.withfloats.com/actual/6a8c35eaca4d2575d78e3716.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c35eaca4d2575d78e3716.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:15:35.873Z", "updatedon": "2026-08-24T12:15:35.873Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-2-mg/2496", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 2 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a6dedd85b0d81b5d5e65e09", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Olanzapine Mouth Dissolving Tablets 2.5 mg", "description": "OLANZPRIME 2.5 is a high-quality pharmaceutical formulation containing Olanzapine 2.5 mg in a convenient mouth dissolving tablet (MDT) dosage form. Developed to support the management of various psychiatric disorders, this formulation is designed to deliver effective therapy while improving patient convenience and treatment adherence. Manufactured in GMP-certified facilities using premium pharmaceutical ingredients, OLANZPRIME 2.5 is produced under strict quality control standards to ensure safety, purity, and consistent performance.\n\nThe rapidly dissolving tablet is formulated to disintegrate quickly on the tongue without the need for water, making it an ideal option for patients who have difficulty swallowing conventional tablets. Its user-friendly dosage form enhances ease of administration while providing dependable therapeutic support under the supervision of a qualified healthcare professional.\n\nComposition\n\nBrand Name: OLANZPRIME 2.5\n\nGeneric Name: Olanzapine\n\nStrength: 2.5 mg\n\nDosage Form: Mouth Dissolving Tablet (MDT)\n\nWhat is OLANZPRIME 2.5?\n\nOLANZPRIME 2.5 contains Olanzapine, an atypical antipsychotic medication that works by regulating the activity of important neurotransmitters such as dopamine and serotonin. By helping restore the balance of these chemical messengers, the medicine supports improved emotional stability, clearer thinking, better behavioral control, and overall mental health.\n\nIts mouth dissolving formulation is specifically designed to provide greater convenience, particularly for individuals who experience difficulty swallowing standard oral tablets.\n\nUses of OLANZPRIME 2.5\n\nOLANZPRIME 2.5 may be recommended by healthcare professionals for the treatment and long-term management of various psychiatric conditions, including:\n\nSchizophrenia\nBipolar disorder, including manic and mixed episodes\nMaintenance therapy for bipolar disorder\nManagement of psychotic symptoms\nSelected behavioral or psychiatric conditions as determined by a physician\n\nThe appropriate dosage and duration of therapy should always be decided by a qualified healthcare provider based on the patient's individual clinical needs.\n\nBenefits of OLANZPRIME 2.5\nQuick-Dissolving Technology\n\nThe tablet dissolves rapidly in the mouth without requiring water, making administration simple and convenient.\n\nImproved Patient Adherence\n\nThe easy-to-take formulation is especially beneficial for elderly patients and individuals with swallowing difficulties, helping improve compliance with prescribed treatment.\n\nProven Antipsychotic Therapy\n\nOlanzapine is a well-established atypical antipsychotic used by healthcare professionals to help manage symptoms associated with schizophrenia and bipolar disorder.\n\nManufactured to High Pharmaceutical Standards\n\nProduced under strict GMP guidelines, OLANZPRIME 2.5 undergoes comprehensive quality testing to ensure consistent safety, efficacy, and product reliability.\n\nConvenient Anytime Administration\n\nThe mouth dissolving dosage form offers flexibility and ease of use, even when drinking water is not readily available.\n\nHow OLANZPRIME 2.5 Works\n\nOlanzapine belongs to the atypical antipsychotic class of medicines. It acts by modulating the activity of dopamine and serotonin receptors in the brain, helping restore a healthy balance of neurotransmitters involved in mood, perception, and behavior.\n\nThis therapeutic action may help reduce symptoms such as:\n\nHallucinations\nDelusional thoughts\nAgitation\nMood fluctuations\nDisorganized thinking\nAnxiety associated with certain psychiatric conditions\n\nWith regular use as prescribed, OLANZPRIME 2.5 helps support mental stability and improves overall quality of life for many patients.\n\nDosage and Administration\n\nTake OLANZPRIME 2.5 exactly as directed by your healthcare professional.\n\nGeneral administration guidelines include:\n\nPlace the tablet directly on the tongue.\nAllow it to dissolve completely before swallowing.\nWater is generally not required.\nTake the medication at the same time each day whenever possible.\nContinue treatment for the duration recommended by your physician.\nDo not stop taking the medicine without medical advice.\nPossible Side Effects\n\nLike all prescription medicines, OLANZPRIME 2.5 may cause side effects in some individuals, although not everyone experiences them.\n\nCommon side effects may include:\n\nDrowsiness\nDizziness\nDry mouth\nIncreased appetite\nWeight gain\nConstipation\nTiredness\n\nSerious or unusual symptoms require prompt medical evaluation. Always consult your healthcare provider if side effects become persistent or concerning.\n\nPrecautions and Warnings\n\nBefore starting OLANZPRIME 2.5, inform your healthcare provider if you have:\n\nDiabetes mellitus\nLiver disorders\nHeart disease\nEpilepsy or seizure disorders\nHigh cholesterol or lipid abnormalities\nHistory of stroke\nKidney impairment\nKnown allergy to Olanzapine or any ingredient in the formulation\n\nAlcohol consumption should generally be avoided during treatment, as it may increase drowsiness and other central nervous system effects.\n\nStorage Instructions\n\nTo preserve product quality:\n\nStore in a cool and dry place.\nProtect from direct sunlight and excessive moisture.\nKeep below the storage temperature mentioned on the product packaging.\nStore in the original blister pack until use.\nKeep out of the reach of children.\nWhy Choose OLANZPRIME 2.5?\n\nOLANZPRIME 2.5 combines trusted antipsychotic therapy with the convenience of mouth dissolving technology, making it an excellent option for patients who require easy administration without compromising treatment effectiveness.\n\nKey Advantages\n\nPremium-quality Olanzapine 2.5 mg formulation\nRapid mouth dissolving tablet for easy administration\nNo water required for consumption\nSupports improved medication compliance\nManufactured under stringent GMP quality standards\nReliable dosage accuracy and product consistency\nSecure packaging designed to maintain product stability\nFrequently Asked Questions (FAQs)\nWhat is OLANZPRIME 2.5 prescribed for?\n\nOLANZPRIME 2.5 is prescribed for the treatment and management of schizophrenia, bipolar disorder, and other psychiatric conditions as determined by a qualified healthcare professional.\n\nDoes this tablet need to be taken with water?\n\nNo. The mouth dissolving tablet is designed to dissolve on the tongue, allowing convenient administration without water.\n\nCan I discontinue OLANZPRIME 2.5 without consulting my doctor?\n\nNo. Treatment should not be stopped suddenly, as abrupt discontinuation may increase the risk of symptom recurrence or withdrawal effects. Always seek medical advice before making any changes to your medication.\n\nIs OLANZPRIME 2.5 appropriate for older adults?\n\nHealthcare professionals may prescribe this medicine for elderly patients when clinically appropriate. Individual dosage adjustments may be necessary depending on the patient's overall health and medical history.\n\nHow long should treatment continue?\n\nThe duration of therapy varies according to the patient's diagnosis, treatment response, and clinical condition. Your healthcare provider will determine the most appropriate treatment plan and monitor progress throughout therapy.", "price": 60.0, "discountamount": 18.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2489, "imageuri": "https://productimages.withfloats.com/actual/6a6deddbc0246085c8f7252b.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a6deddbc0246085c8f7252b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-01T13:00:08.65Z", "updatedon": "2026-08-01T13:00:08.65Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//olanzapine-mouth-dissolving-tablets-2-5-mg/2489", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OLANZPRIME 2.5", "category": "NEUROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a5df8cd5046d247bd5a48c2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Arpiprazole Mouth Dissolving Tablets 15 mg", "description": "ARPIPRAZ 15 is a mouth-dissolving tablet containing Aripiprazole 15 mg, prescribed for schizophrenia, bipolar disorder, autism-related irritability, Tourette's disorder, and as an add-on to antidepressants for major depressive disorder. Unlike many antipsychotics that fully block dopamine, Aripiprazole acts as a partial dopamine agonist, fine-tuning rather than shutting down dopamine activity — which can mean fewer movement-related side effects for some patients. The tablet dissolves on the tongue without water, helping patients who struggle with swallowing. It's not considered habit-forming but must be taken exactly as prescribed and never stopped abruptly. Prescription only – consult your doctor.\n\nMeta Title Options (50–60 characters)\nARPIPRAZ 15 Price – Aripiprazole MD Tablet | Steris (Recommended)\nARPIPRAZ 15 – Aripiprazole Mouth Dissolving Tablet\nARPIPRAZ 15 Price – Schizophrenia & Bipolar Care\nAripiprazole 15mg MD Tablet – ARPIPRAZ Price\nARPIPRAZ 15 – Antipsychotic for Multiple Conditions\n\nRationale: Option 1 leads with the “Price” anchor required for this Schedule H drug, keeps the brand searchable alongside the generic name, and fits within the 50–60 character band.\n\nMeta Description (140–160 characters)\n\nARPIPRAZ 15 (Aripiprazole 15mg MD) treats schizophrenia, bipolar disorder & more. Check price online. Prescription only – consult your doctor first.\n\nFull CMS Article\nARPIPRAZ 15: Aripiprazole Mouth Dissolving Tablet for Schizophrenia, Bipolar Disorder, and Related Conditions\nTL;DR / AI Mode Summary\n\nARPIPRAZ 15 supplies Aripiprazole 15 mg in a mouth-dissolving format, used across a broader range of conditions than many antipsychotics — schizophrenia, bipolar disorder, autism-related irritability, Tourette's disorder, and as an adjunct to antidepressant therapy in major depressive disorder. Its defining feature is a partial dopamine agonist mechanism: rather than fully blocking dopamine like older antipsychotics, it modulates it, which is associated with a comparatively lower risk of certain movement side effects. The dissolving tablet skips the need for water, supporting patients who find conventional tablets hard to swallow.\n\nWhat Sets ARPIPRAZ 15 Apart?\n\nMost antipsychotic medicines work by blocking dopamine receptors outright. Aripiprazole takes a different approach — it acts as a partial agonist, meaning it can either boost or dampen dopamine activity depending on what the brain's current chemical state calls for. This “smart stabilizer” action is one reason Aripiprazole is prescribed across such a wide span of psychiatric conditions, from psychotic disorders to mood conditions to certain neurodevelopmental and tic-related presentations.\n\nComposition at a Glance\nAttribute\tDetail\nBrand Name\tARPIPRAZ 15\nActive Ingredient\tAripiprazole\nStrength\t15 mg\nForm\tMouth Dissolving Tablet (MD)\nDrug Class\tAtypical Antipsychotic — Partial Dopamine Agonist\nSchedule Status\tSchedule H – Prescription Only\nConditions ARPIPRAZ 15 Is Prescribed For\n\nSchizophrenia — helps ease hallucinations, delusions, disorganized thought, social withdrawal, and reduced motivation, supporting better day-to-day and social functioning.\n\nBipolar I Disorder — used for acute manic and mixed episodes, as well as maintenance therapy aimed at reducing relapse.\n\nMajor Depressive Disorder (adjunct) — added alongside antidepressants when depression hasn't responded fully to antidepressant treatment alone.\n\nIrritability Linked to Autism Spectrum Disorder — may reduce aggression, irritability, outbursts, and self-injurious behavior in eligible patients.\n\nTourette's Disorder — can reduce the frequency and intensity of motor and vocal tics for some patients.\n\nMechanism of Action\n\nAripiprazole works on three key receptor systems:\n\nDopamine D2 receptors — partially activated rather than fully blocked, helping normalize rather than suppress dopamine signaling\nSerotonin 5-HT1A receptors — contributing to mood stabilization and reduced anxiety\nSerotonin 5-HT2A receptors — supporting the reduction of psychotic symptoms\n\nTogether, this receptor profile helps ease hallucinations and delusions, stabilize mood swings, reduce anxiety, and support clearer cognitive functioning — while the partial-agonist approach is associated with a comparatively lower likelihood of certain movement-related side effects compared to older-generation antipsychotics.\n\nDirections for Use\nTake ARPIPRAZ 15 strictly as your doctor prescribes.\nPlace the tablet on the tongue and let it dissolve fully — no water is typically needed.\nDon't chew or crush it unless your doctor specifically advises otherwise.\nTake it at a consistent time each day.\nContinue the full course even once you start feeling better, unless your doctor says otherwise.\nNever discontinue suddenly on your own — stopping abruptly can bring symptoms back.\nPossible Side Effects\n\nCommonly reported:\n\nHeadache\nDizziness\nNausea or vomiting\nConstipation\nDry mouth\nRestlessness\nAnxiety\nInsomnia\nFatigue\nIncreased appetite\nWeight changes\n\nSerious — seek immediate medical attention for:\n\nSevere allergic reactions\nHigh fever combined with muscle stiffness\nSeizures\nDifficulty swallowing\nUncontrolled body movements\nFainting\nIrregular heartbeat\nSuicidal thoughts or sudden behavioral changes\n\nPlaceholder: incidence rates and comparative trial data pending qualified clinical reviewer sign-off before publication.\n\nTalk to your doctor promptly if any side effect feels severe or doesn't improve.\n\nWho Should Be Cautious\n\nLet your doctor know before starting if you have any of the following:\n\nDiabetes\nHeart disease, or high or low blood pressure\nLiver or kidney impairment\nSeizure disorders\nParkinson's disease\nDementia\nA history of stroke\nA history of substance use\n\nLong-term treatment often includes periodic checks of blood sugar, body weight, and general health.\n\nPregnancy & Breastfeeding\n\nAripiprazole should be used in pregnancy or while breastfeeding only if a doctor determines the benefits outweigh the potential risks. This decision should always be made in consultation with your healthcare provider.\n\nDrug Interactions to Flag for Your Doctor\n\nARPIPRAZ 15 can interact with:\n\nAntidepressants and anti-anxiety medicines\nAntiepileptic drugs\nBlood pressure medications\nCertain antifungal medicines and antibiotics\nHIV medications\nSleeping pills\nAlcohol\n\nShare a complete list of everything you're taking — prescription drugs, over-the-counter products, vitamins, and herbal supplements — with your prescriber before starting treatment.\n\nPrecautions & Storage\nTake only as prescribed; don't adjust the dose independently.\nAvoid alcohol during treatment.\nStore below 25°C, in the original packaging, away from moisture and direct sunlight.\nKeep out of reach of children.\nDon't use beyond the printed expiry date.\nHow ARPIPRAZ 15 Compares to Other Antipsychotics\nFeature\tOlder-Generation Antipsychotics\tARPIPRAZ 15 (Aripiprazole)\nDopamine Action\tFull receptor blockade\tPartial agonist — modulates rather than blocks\nMovement-Related Side Effect Risk\tComparatively higher\tComparatively lower for many patients\nRange of Approved Uses\tTypically narrower\tBroader — includes autism-related irritability and Tourette's\nAdministration\tUsually standard tablets\tAvailable in swallow-free MD format\n\nNote: The right antipsychotic and formulation is a clinical decision made by a psychiatrist based on individual patient factors.\n\nWhy Choose ARPIPRAZ 15?\n\nBeyond its versatility across several psychiatric and neurodevelopmental conditions, ARPIPRAZ 15's mouth-dissolving format removes a real practical hurdle for patients who struggle with regular tablets. It isn't considered habit-forming, and its partial-agonist mechanism offers a distinct option for psychiatrists balancing symptom control against side-effect tolerability. Manufactured to consistent quality standards, it's built for dependable day-to-day use under medical supervision.\n\nConclusion\n\nWhether the goal is easing psychotic symptoms, stabilizing mood in bipolar disorder, supporting antidepressant therapy, or reducing irritability and tics in specific conditions, ARPIPRAZ 15 offers a versatile treatment option built on Aripiprazole's distinctive dopamine-modulating action. Its dissolving tablet format simplifies daily dosing, and with consistent use under a psychiatrist's care, it supports steadier symptom management over time. Prescription only – consult your doctor.\n\nFrequently Asked Questions\nWhat is ARPIPRAZ 15 used for? It treats schizophrenia, bipolar disorder, autism-related irritability, and Tourette's disorder, and is used as an add-on treatment for major depressive disorder.\nCan it be taken without water? Yes, it's a mouth-dissolving tablet designed to break down on the tongue without needing water.\nIs ARPIPRAZ 15 habit-forming? No, Aripiprazole isn't considered habit-forming, though it should always be used under medical supervision.\nCan I stop taking it once I feel better? No — stopping without medical guidance can cause symptoms to return; any discontinuation should be doctor-directed.\nDoes it cause weight gain? Some patients notice weight changes during treatment; a balanced diet and regular activity can help manage this.\nHow is ARPIPRAZ 15 different from other antipsychotics? It works as a partial dopamine agonist rather than fully blocking dopamine, which is linked to a lower risk of certain movement-related side effects for many patients.\nCan this medicine be used for depression? Yes, it's sometimes added alongside antidepressants when depression hasn't responded fully to antidepressant treatment alone.\nIs it suitable for autism-related irritability? It's prescribed for irritability associated with autism spectrum disorder in eligible patients, under a specialist's guidance.\nDoes ARPIPRAZ 15 interact with alcohol? Yes, alcohol should generally be avoided during treatment, as it may affect the medicine's tolerability.\nWhat serious symptoms require urgent medical attention? Severe allergic reactions, high fever with muscle stiffness, seizures, uncontrolled movements, fainting, irregular heartbeat, or sudden behavioral changes need immediate care.\nWhat health conditions should I mention to my doctor beforehand? Diabetes, heart disease, blood pressure issues, liver or kidney impairment, seizure disorders, Parkinson's disease, dementia, stroke history, and substance use history should all be disclosed.\nCan ARPIPRAZ 15 be used in pregnancy? Only if your doctor determines the benefits outweigh potential risks — this should always be discussed directly with your healthcare provider.\nDoes this medicine interact with other drugs I'm taking? It can interact with several medicine classes, including antidepressants, antiepileptics, blood pressure drugs, and certain antibiotics or antifungals — share your full medication list with your doctor.\nIs a prescription required to purchase ARPIPRAZ 15? Yes, it's a Schedule H medicine dispensed only against a valid doctor's prescription.\nHow long does it take to see results? Response time varies by condition and individual; your psychiatrist will track progress through follow-up visits.\n\n[Steris Healthcare Footer] Manufactured and marketed by Steris Healthcare Pvt. Ltd. — a WHO-GMP and ISO-certified pharmaceutical manufacturer. For queries, reach us at contact@sterispharma.com or +91 8824175417. This content is for informational purposes only and does not replace professional medical advice. Prescription only – consult your doctor.", "price": 210.0, "discountamount": 63.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2480, "imageuri": "https://productimages.withfloats.com/actual/6a5df8cfa4709fd448b5e572.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a5df8cfa4709fd448b5e572.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-20T10:30:37.014Z", "updatedon": "2026-07-20T10:30:37.014Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//arpiprazole-mouth-dissolving-tablets-15-mg/2480", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ARPIPRAZ 15", "category": "NEUROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a5df739c15b0b6844e869c2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Olanzapine Mouth Dissolving Tablets 20 mg", "description": "OLANZPRIME 20 is a 20 mg Olanzapine mouth-dissolving tablet used to manage schizophrenia and bipolar disorder, typically for patients whose psychiatrist has determined a higher dose is appropriate than the standard 15 mg strength. It calms overactive dopamine and serotonin signaling in the brain, easing hallucinations, delusions, and mood instability. The tablet dissolves on the tongue in seconds, so no water is needed — a practical advantage for elderly patients or anyone who struggles with swallowing. Because higher-dose Olanzapine carries a somewhat greater chance of metabolic side effects like weight gain, regular monitoring is often advised. Prescription only – consult your doctor.\n\nMeta Title Options (50–60 characters)\nOLANZPRIME 20 Price – Olanzapine 20mg MD Tablet (Recommended)\nOLANZPRIME 20mg – Mouth Dissolving Antipsychotic\nOLANZPRIME 20 Price – Higher-Dose Olanzapine MD\nOlanzapine 20mg MD Tablet – OLANZPRIME Price Online\nOLANZPRIME 20 – Schizophrenia & Bipolar MD Tablet\n\nRationale: Option 1 leads with the “Price” anchor required for this Schedule H product and specifies the 20 mg strength clearly, helping differentiate it in search from the 15 mg SKU while staying within character limits.\n\nMeta Description (140–160 characters)\n\nOLANZPRIME 20 delivers higher-dose Olanzapine in an MD tablet for schizophrenia & bipolar care. Check price online. Prescription only – doctor advised.\n\nFull CMS Article\nOLANZPRIME 20: Higher-Strength Olanzapine Mouth Dissolving Tablet for Psychiatric Care\nTL;DR / AI Mode Summary\n\nOLANZPRIME 20 provides Olanzapine at a 20 mg strength in a fast-dissolving tablet form, prescribed for schizophrenia, bipolar disorder, and related conditions where a psychiatrist determines a higher dose is clinically needed. Like other Olanzapine formulations, it works on dopamine and serotonin pathways to steady mood and reduce psychotic symptoms. The dissolving format skips the need for water, which helps with adherence in patients who find tablet-swallowing difficult. Given the higher strength, monitoring for metabolic changes — weight, blood sugar, lipids — is a routine part of long-term care.\n\nUnderstanding OLANZPRIME 20\n\nNot every patient responds the same way to a starting dose of Olanzapine. Where symptoms remain inadequately controlled at lower strengths, or where a psychiatrist's clinical judgment calls for a higher therapeutic level, OLANZPRIME 20 offers the 20 mg strength in the same convenient mouth-dissolving format — sparing patients the need to switch to swallowing multiple lower-strength tablets or handle water-based dosing.\n\nComposition at a Glance\nAttribute\tDetail\nBrand Name\tOLANZPRIME 20\nActive Ingredient\tOlanzapine\nStrength\t20 mg\nForm\tMouth Dissolving Tablet (MD)\nRoute\tOral\nTherapeutic Class\tAtypical Antipsychotic\nSchedule Status\tSchedule H – Prescription Only\nConditions It's Prescribed For\nSchizophrenia\nBipolar I Disorder, including acute manic episodes\nLong-term maintenance care for bipolar disorder\nPsychotic disorders more broadly\nMood disorders, at a psychiatrist's discretion\nAgitation linked to certain psychiatric presentations\n\nThe aim across these conditions is the same: dial down hallucinations, delusions, and disorganized thought enough that patients can re-engage with daily routines and relationships.\n\nMechanism of Action\n\nSymptoms like hallucinations, mood swings, and confused thinking are strongly linked to overactive dopamine (D2) receptor signaling, along with disrupted serotonin (5-HT2A) activity in the brain.\n\nAt the 20 mg strength, Olanzapine:\n\nBlocks excess dopamine receptor activity more fully than lower doses may achieve\nModulates serotonin signaling alongside dopamine\nEases hallucinations, delusions, and anxiety tied to psychotic symptoms\nSupports steadier mood and reduced aggression\nHelps restore clearer, more organized thinking\n\nThe mouth-dissolving format means the tablet breaks down on the tongue within moments, which is particularly useful for elderly patients or anyone managing swallowing difficulty alongside their psychiatric condition.\n\nDirections for Use\nTake OLANZPRIME 20 only in the dose and frequency your psychiatrist prescribes — do not self-adjust to a higher or lower strength.\nPlace the tablet on the tongue and let it dissolve fully without chewing.\nSwallow once dissolved; water isn't usually necessary.\nTake it at a consistent time each day.\nComplete the full course your doctor recommends, even if you start feeling better.\nNever stop abruptly — sudden discontinuation can trigger symptom relapse or withdrawal-type effects.\nPossible Side Effects\n\nCommon, generally manageable effects include:\n\nDrowsiness or sleepiness\nIncreased appetite\nWeight gain\nDry mouth\nConstipation\nDizziness\nFatigue\nTremors\nRestlessness\n\nLess common but more serious effects can include severe allergic reactions, uncontrolled muscle movements, very high fever, or signs of elevated blood sugar. Because the 20 mg strength is a higher dose, these metabolic and neurological effects warrant closer attention.\n\nPlaceholder: incidence rates and dose-comparison trial data pending qualified clinical reviewer sign-off before publication.\n\nSeek emergency care immediately if any of these serious symptoms appear.\n\nWho Should Be Cautious\n\nShare your full medical history with your doctor before starting, especially if you have:\n\nDiabetes or a family history of diabetes\nLiver or kidney disease\nHeart disease\nHigh cholesterol or triglycerides\nEpilepsy or seizure disorders\nGlaucoma\nParkinson's disease\nDementia, particularly in older patients\nA prior stroke\nPrecautions & Lifestyle Considerations\nAvoid alcohol, since it can compound drowsiness.\nBe cautious with driving or operating machinery until you know how the medicine affects you.\nBecause Olanzapine — especially at higher strengths — can contribute to weight gain, a balanced diet and regular activity are worth building into your routine.\nLong-term treatment typically includes periodic checks of blood sugar, lipid levels, and body weight.\nIn pregnancy or while breastfeeding, use only if your doctor has weighed the benefits against potential risks.\nStorage Instructions\nStore below 25°C, protected from moisture, heat, and direct sunlight.\nKeep tablets in the original blister pack until the moment of use.\nKeep out of reach of children.\nDo not use past the expiry date printed on the pack.\nComparing Olanzapine Strengths\nStrength\tTypical Scenario\tConsiderations\nOLANZPRIME 15 (15 mg)\tStandard starting or maintenance dose\tSuitable for many patients as an initial therapeutic level\nOLANZPRIME 20 (20 mg)\tHigher therapeutic need per psychiatrist's assessment\tMay carry a somewhat greater likelihood of metabolic side effects; monitoring emphasized\n\nNote: The right strength is determined entirely by a psychiatrist's clinical assessment — patients should never switch strengths on their own.\n\nWhy Choose OLANZPRIME 20?\n\nFor patients who need a higher Olanzapine dose but still benefit from a swallow-free administration route, OLANZPRIME 20 combines both. It's manufactured to consistent pharmaceutical quality standards, giving psychiatrists, hospitals, and pharmacies a dependable higher-strength option without sacrificing the ease-of-use that mouth-dissolving tablets are known for.\n\nConclusion\n\nManaging schizophrenia or bipolar disorder sometimes calls for a higher Olanzapine dose than a standard starting regimen provides. OLANZPRIME 20 delivers that strength in a mouth-dissolving format that keeps daily administration simple, even for patients who find conventional tablets difficult to manage. Taken consistently under a psychiatrist's supervision, with regular monitoring for metabolic changes, it supports steadier, more manageable day-to-day functioning. Prescription only – consult your doctor.\n\nFrequently Asked Questions\nWhat is OLANZPRIME 20 used for? It's prescribed for schizophrenia, bipolar disorder, and other psychiatric conditions where a psychiatrist determines this higher strength is appropriate.\nHow is OLANZPRIME 20 different from OLANZPRIME 15? Both contain Olanzapine in the same mouth-dissolving format; OLANZPRIME 20 is a higher 20 mg strength used when a psychiatrist assesses that a greater dose is clinically needed.\nHow should I take it? Place the tablet on your tongue, let it dissolve fully, and swallow naturally — always following your doctor's exact dosing.\nDo I need water to take this tablet? No, it's designed to dissolve on the tongue without water.\nCan OLANZPRIME 20 cause weight gain? Yes, weight gain and increased appetite are known effects, and the risk may be somewhat higher at this strength — regular monitoring and healthy habits can help manage it.\nIs this strength safe for long-term use? Yes, under a psychiatrist's ongoing supervision, with periodic checks of weight, blood sugar, and lipid levels.\nCan I switch from OLANZPRIME 15 to OLANZPRIME 20 on my own? No — any change in strength must be directed by your prescribing psychiatrist.\nWhat happens if I stop taking it suddenly? Stopping abruptly can lead to symptom relapse or withdrawal-type effects; any discontinuation should be gradual and doctor-guided.\nDoes alcohol interact with OLANZPRIME 20? Yes, alcohol can intensify drowsiness and should generally be avoided during treatment.\nIs it safe to drive while taking this medicine? Use caution with driving or operating machinery until you understand how the medicine affects your alertness and coordination.\nWhat health conditions should I disclose before starting? Mention diabetes, liver or kidney disease, heart disease, high cholesterol, epilepsy, glaucoma, Parkinson's disease, dementia, or a history of stroke.\nWhat serious symptoms need immediate medical attention? Severe allergic reactions, uncontrolled muscle movements, very high fever, or signs of very high blood sugar require urgent care.\nCan this be used during pregnancy? Only under medical supervision, after your doctor weighs the potential benefits against risks.\nIs a prescription required to buy OLANZPRIME 20? Yes, it is a Schedule H medicine and can only be dispensed against a valid doctor's prescription.\nHow long until I notice improvement? This varies by individual and condition; your psychiatrist will track progress through scheduled follow-ups.\n\n[Steris Healthcare Footer] Manufactured and marketed by Steris Healthcare Pvt. Ltd. — a WHO-GMP and ISO-certified pharmaceutical manufacturer. For queries, reach us at contact@sterispharma.com or +91 8824175417. This content is for informational purposes only and does not replace professional medical advice. Prescription only – consult your doctor.", "price": 245.0, "discountamount": 73.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2479, "imageuri": "https://productimages.withfloats.com/actual/6a5df73c6c57d63669881829.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a5df73c6c57d63669881829.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-20T10:23:53.814Z", "updatedon": "2026-07-20T10:23:53.814Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//olanzapine-mouth-dissolving-tablets-20-mg/2479", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OLANZPRIME 20", "category": "NEUROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

Still searching for
650 mg?

Still searching for
650 mg?

Chat with us